| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Sato Vicki L is a Director at VIR with holdings across 5 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $16.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | DNLI Denali Therapeutics Inc. | Director | Sell | 3,080 | $20.91 | $64,402.80 | -2.8% | -34.1% | -21.9% | |
| Nov 7, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,020 | $30.00 | $30,600.00 | -0.9% | -20.3% | -49.3% | |
| Nov 1, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 3,080 | $27.07 | $83,375.60 | -2.7% | -12.8% | -39.8% | |
| Sep 13, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,020 | $30.00 | $30,600.00 | -0.9% | -23.7% | -53.9% | |
| Sep 3, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 3,080 | $25.00 | $77,007.20 | -1.3% | +2.0% | -39.1% | |
| Jul 1, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 3,080 | $22.14 | $68,203.60 | -1.3% | +32.3% | -36.6% | |
| May 15, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,674 | $20.39 | $34,132.86 | -1.4% | +10.4% | -32.1% | |
| Apr 15, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $18.29 | $30,471.14 | -1.4% | +30.8% | -26.2% | |
| Mar 15, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $20.10 | $33,486.60 | -1.4% | +9.9% | -24.7% | |
| Feb 15, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $18.37 | $30,604.42 | -1.4% | +13.6% | +16.4% |